Vanguard Global Advisers
ASMB icon

Vanguard Global Advisers’s Assembly Biosciences ASMB Stock Holding History

Vanguard Global Advisers’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Hold
4,615
– – ﹤0.01% 2684
2026
Q1 		$128K Buy
+4,615
New +$132K ﹤0.01% 2630

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Global Advisers's ASMB Position: Q2 2026 in Review

Vanguard Global Advisers held its Assembly Biosciences (ASMB) position steady in Q2 2026 at 4,615 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Vanguard Global Advisers first reported a position in ASMB in Q1 2026 and has held it in 2 quarters since. The position peaked at $128K in Q1 2026. 92 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Vanguard Global Advisers held 4,615 shares of Assembly Biosciences worth $127K as of Q2 2026.
  • Vanguard Global Advisers left its Assembly Biosciences share count unchanged in Q2 2026.
  • Assembly Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2684 holding.
  • Vanguard Global Advisers first reported a position in Assembly Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Assembly Biosciences position peaked at $128K in Q1 2026.
  • 92 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.